Recent work published by researchers at the University of Kentucky’s Sanders-Brown Center on Aging (SBCoA) highlights what the lead investigator calls the “cornerstone” of her lab.
A new University of Kentucky College of Medicine study may provide answers for why so many COVID-19 patients experience thrombosis, or the formation of blood clots that obstruct blood flow through the circulatory system.
As the COVID-19 pandemic persists, children across the country are facing social isolation. With many school districts in the U.S. choosing remote learning, students are likely to consume more mass media. You might be wondering, should parents be concerned?
A new University of Kentucky College of Medicine study provides insight into how a protein called angiotensinogen contributes to blood pressure regulation and atherosclerosis.
The paper explains that current therapeutic approaches to the treatment of Alzheimer’s disease focus on the major pathological hallmarks of the disease which are amyloid plaques and neurofibrillary tangles. They are the requirements for a diagnosis of Alzheimer’s disease. However, the authors say there has been an explosion of genetic data suggesting the risk for sporadic Alzheimer’s disease is driven by several other factors including neuroinflammation, membrane turnover and storage, and lipid metabolism.
Working with their colleagues at the University of Pennsylvania, researchers at the University of Kentucky have found that they can differentiate between subtypes of dementia inducing brain disease. “For the first time we created criteria that could differentiate between frontotemporal dementia (FTD) and a common Alzheimer’s ‘mimic’ called LATE disease,” explained Dr. Peter Nelson of the Sanders-Brown Center on Aging at the University of Kentucky.
Coal-to-carbon fiber research shows great promise to positively impact the nation’s sluggish coal industry.
University of Kentucky researcher Nika Larian has been awarded a Science & Technology Policy Fellowship with the American Association for the Advancement of Science.
PDS Biotechnology, a clinical stage immunotherapy company, has announced positive results from preclinical testing conducted at the University of Kentucky College of Medicine of its COVID-19 vaccine candidate, PDS0203.
Used as a medicinal herb for centuries, Artemisia annua contains powerful compounds that make it a popular treatment for malaria. But with lab research showing these compounds may help treat a variety of cancers and even COVID-19, this plant is more relevant than ever -- and UK is showing how we can take it from Kentucky fields to the research lab to our patients.
The COVID-19 pandemic brought many things to a screeching halt and continues to impact our daily lives. However, important research at the University of Kentucky’s Sanders-Brown Center on Aging (SBCoA) is continuing under extreme caution and deep dedication. A monumental study in the field of dementia research is set to get underway in the coming weeks at UK.
A new study by researchers at the University of Kentucky identifies a novel function of the enzyme spermine synthase to facilitate colorectal cancer growth.
University of Kentucky virologist Rebecca Dutch answers key questions about SARS-CoV-2 and the coronavirus pandemic.
“When I first saw the text inside the scroll, it felt like I was a kid again — like digging through the sand for fossils at one of those museum exhibits and actually finding one. I was so excited,” Tamasi said. “I was the first person to see the contents of the scroll this millennium. There aren’t many opportunities like that.”
Researchers at the University of Kentucky’s Sanders-Brown Center on Aging (SBCoA) recently screened the first participant in the world for what is known as the AHEAD 3-45 study. This work is looking at a study medication, BAN2401, to determine if it can help prevent worsening memory and thinking among individuals who might be at risk for future decline. They are hoping this study finds that BAN2401 does just that and will ultimately help prevent Alzheimer’s disease.
The long-running study on aging and brain health at the University of Kentucky’s Sanders-Brown Center on Aging Alzheimer’s Disease Center has once again resulted in important new findings – highlighting a complex and under-recognized form of dementia.
The University of Kentucky announced a research collaboration with Atomwise, an industry leader in using artificial intelligence (AI) for small molecule discovery, to explore potential COVID-19 therapies.
Today, Juneteenth — which celebrates the abolition of slavery — coincides with protests across the U.S. against racial injustice. Society has become inspired to renew their interest in African American history — a legacy filled with tragedy, inequality, resilience and survival. In a Q&A session, UK's Vanessa Holden shares her expertise and insight on the holiday.
University of Kentucky College of Medicine researchers are using special antibodies made by alpacas to help understand COVID-19 and potentially develop a treatment that could protect people from being infected.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right